23andMe Holding Co.

As of June 4, 2025, the market trend is sideways with mixed signals from indicators, showing bullish momentum on the weekly MACD and KST but bearish on the RSI and daily moving averages, indicating a lack of clear direction.

23andMe Holding Co. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $45 million and a net loss of $99 million as of March 2025. It has a market cap of $109.62 million and no dividend yield.

As of Jun 18, 23andMe Holding Co. has a market capitalization of 109.62 million, with net sales of 189.89 million and a net profit of -262.12 million over the last four quarters. Shareholder's funds are 188.52 million, and total assets are 395.17 million.